Axon Enterprise, Inc $AXON Shares Sold by First Trust Advisors LP
π First Trust Advisors LP trimmed its AXON holdings by 21.3% in Q1, reducing its position to 77,155 shares valued at $32.8 million.
π Sound Income Strategies LLC boosted its stake by 550%, while Creative Financial Designs Inc. and others established new positions totaling over $100k combined.
π― Needham & Company raised the price target to $750 with a 'Buy' rating, and JPMorgan Chase increased its target to $755 with an 'Overweight' rating.
π° Axon reported Q1 revenue of $807.35 million, beating estimates by nearly $29 million and growing 33.7% year-over-year.
π The company posted EPS of $1.61, exceeding the consensus estimate of $1.60, with a net margin of 6.90% and return on equity of 3.78%.
π‘οΈ Axon's hardware portfolio includes TASER devices and body-worn cameras paired with a subscription-based digital evidence management software platform.
πΌ CEO Patrick W. Smith sold 10,000 shares for $6.44 million under a Rule 10b5-1 plan, retaining over 3 million shares personally.
π Corporate insiders sold approximately 59,000 shares worth $30.5 million in the last three months, though they still own 4.20% of the company.
π The stock trades at a P/E ratio of 219.94 with a market cap of $44.14 billion and a beta of 1.38 indicating higher volatility.
π Institutional ownership stands at 79.08%, reflecting significant interest from hedge funds and asset managers in the public safety technology sector.
- Axon Enterprise reported Q1 revenue of $807.35 million, a 33.7% increase year-over-year that significantly beat analyst consensus estimates.
- The company posted earnings per share of $1.61, surpassing the expected $1.60 estimate, demonstrating strong profitability with a 6.90% net margin.
- Needham & Company raised its price target to $750 and issued a 'Buy' rating, signaling confidence in the company's growth trajectory.
- JPMorgan Chase increased its price target to $755 and maintained an 'Overweight' rating, reinforcing positive analyst sentiment.
- The stock has a consensus target price of $725.25 based on 18 analysts, with 15 recommending a Buy compared to only 3 Holds.
- Axon maintains a strong balance sheet with a quick ratio of 1.93 and a current ratio of 2.27, indicating robust liquidity management.
- CEO Patrick W. Smith retains over $1.96 billion in company stock personally, showing significant skin in the game despite recent sales.
- First Trust Advisors LP reduced its stake by 21.3% in Q1, indicating a notable decrease in institutional confidence from this major investor.
- Corporate insiders sold approximately $30.5 million worth of shares over the last three months, including significant sales by the CEO and a director.
- The stock trades at a high P/E ratio of 219.94, suggesting that current valuation may be sensitive to any slowdown in growth or earnings misses.